Tobacco Cessation Care for Cancer Patients by Automated Interactive Outreach

Last updated: February 11, 2026
Sponsor: University of California, San Francisco
Overall Status: Completed

Phase

N/A

Condition

Tobacco Use Disorder

Neoplasms

Cancer

Treatment

Biospecimen samples

CareConnect

AutoReach

Clinical Study ID

NCT05829824
226310
NCI-2023-03215
  • Ages > 18
  • All Genders

Study Summary

This is a multi-arm, randomized controlled, pilot study which will recruit cancer patients who have been seen by a UCSF Cancer Center-affiliated clinical department to evaluate the efficacy of "CareConnect". This is the first study to assess the efficacy CareConnect, a combination of the Ask-Advise-Connect (AAC) with an Interactive Voice Response (IVR) delivering cancer-targeted educational messages to support referral to smoking cessation resources for patients with cancer.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age 18 years and older.

  2. Able to understand study procedures and to comply with them for the entire length ofthe study.

  3. Ability of individual or legal guardian/representative to understand a writteninformed consent document, and the willingness to sign it.

  4. English, Spanish, Cantonese, or Mandarin speaking.

  5. Self-reported current use of tobacco, including e-cigarette on EHR.

  6. Has a diagnosis of cancer.

  7. Has been seen by a prescribing provider within a UCSF Cancer Center-affiliatedclinical department within the past 3 months.

Exclusion

Exclusion Criteria:

  1. Contraindication to any study-related procedure or assessment.

  2. No valid contact telephone number.

  3. Currently hospitalized or having been discharged from inpatient setting within thepast month (according to EHR).

Study Design

Total Participants: 400
Treatment Group(s): 3
Primary Treatment: Biospecimen samples
Phase:
Study Start date:
November 27, 2023
Estimated Completion Date:
August 15, 2025

Study Description

PRIMARY OBJECTIVE:

I. To evaluate CareConnect's efficacy on referring patients to tobacco cessation resources.

SECONDARY OBJECTIVE:

I. To evaluate patients' acceptance of referrals.

II. To evaluate the acceptability of CareConnect.

EXPLORATORY OBJECTIVES:

I. In-depth semi-structured qualitative interviews of 20 selectively chosen participants who completed the 3-month follow-up survey or finished the automated CareConnect or Auto-Reach call but may have refused to complete the 3-month follow-up survey (10 from each group).

II. Smoking cessation with verification.

OUTLINE:

Eligible participants, identified through the Cancer Center Tobacco Registry will be randomized to either the Intervention or Control arm on a 1:1 ratio. Participants who complete the first call of CareConnect or AutoReach will be considered enrolled. Participants will complete a baseline assessment, a 3-month assessment, and have option to provide a saliva sample.

For those who are selected to participate in an in-depth interview, this will take place within 1 month after the 3-month assessment. Data from the participants medical record may be accessed at 6 months post follow-up.

Connect with a study center

  • University of California, San Francisco

    San Francisco, California 94143
    United States

    Site Not Available

  • University of California, San Francisco

    San Francisco 5391959, California 5332921 94143
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.